Scabies Surveillance Study
Cross-source consensus on Scabies Surveillance Study from 1 sources and 6 claims.
1 sources · 6 claims
Dosage & preparation
Evidence quality
Other
Highlighted claims
- The study reported 323,106 new scabies cases from January 2021 through December 2023. — Seasonality of scabies and its association with climatic factors in Rohingya refugee camps, Cox’s Bazar: a retrospective observational study, 2021–2023
- The study used routine health data from 35 IOM-supported health facilities from 1 January 2021 to 31 December 2023. — Seasonality of scabies and its association with climatic factors in Rohingya refugee camps, Cox’s Bazar: a retrospective observational study, 2021–2023
- All clinically diagnosed and treated scabies patients at the selected facilities during 2021 to 2023 were included. — Seasonality of scabies and its association with climatic factors in Rohingya refugee camps, Cox’s Bazar: a retrospective observational study, 2021–2023
- Data from 2024 onward were excluded because mass drug administration altered transmission patterns. — Seasonality of scabies and its association with climatic factors in Rohingya refugee camps, Cox’s Bazar: a retrospective observational study, 2021–2023
- Cases were identified through passive outpatient surveillance and diagnosed clinically using Médecins Sans Frontières clinical guidelines. — Seasonality of scabies and its association with climatic factors in Rohingya refugee camps, Cox’s Bazar: a retrospective observational study, 2021–2023
- Topical 5% permethrin cream was the primary treatment for diagnosed cases. — Seasonality of scabies and its association with climatic factors in Rohingya refugee camps, Cox’s Bazar: a retrospective observational study, 2021–2023